Literature DB >> 30096244

Long noncoding RNA NEAT1 promotes the growth of cervical cancer cells via sponging miR-9-5p.

Qiuxian Xie1,1, Shanna Lin1,1, Manjia Zheng1,1, Qiutao Cai1,1, Ya Tu1,1.   

Abstract

Evidence has accumulated demonstrating that long noncoding RNAs (lncRNAs) participate in the initiation and progression of cancers. In this study, we found that the lncRNA nuclear paraspeckle assembly transcript 1 (NEAT1) is significantly increased in both cervical cancer tissues and cell lines. Overexpression of NEAT1 promoted the proliferation and migration of cervical cancer cells. Molecular studies uncovered that NEAT1 functions as competitive endogenous RNA (ceRNA), binding the micro-RNA miR-9-5p and suppressing its expression. However, we consistently found that when NEAT1 was highly expressed, it attenuated the inhibitory effect of miR-9-5p on the expression of PTEN and POU2F1, which are the targets of miR-9-5p. Consistent with the negative regulation of NEAT1 on miR-9-5p, restoration of miR-9-5p inhibited the growth-promoting effects of NEAT1 on cervical cancer cells. Taken together, these results indicated that NEAT1 plays an important role in the regulation cervical cancer cell growth by targeting miR-9-5p. Our findings characterized the possible mechanism of NEAT1 in cervical cancer.

Entities:  

Keywords:  NEAT1; cancer du col utérin; cell growth; cervical cancer; croissance cellulaire; miR-9-5p

Mesh:

Substances:

Year:  2018        PMID: 30096244     DOI: 10.1139/bcb-2018-0111

Source DB:  PubMed          Journal:  Biochem Cell Biol        ISSN: 0829-8211            Impact factor:   3.626


  24 in total

Review 1.  The Role of Long Non-coding RNA, Nuclear Enriched Abundant Transcript 1 (NEAT1) in Cancer and Other Pathologies.

Authors:  Miao Zhang; Jianmin Guo; Lifei Liu; Mei Huang; Yuexuan Li; Samuel Bennett; JiaKe Xu; Jun Zou
Journal:  Biochem Genet       Date:  2021-10-24       Impact factor: 1.890

2.  Chrysophanol suppresses growth and metastasis of T cell acute lymphoblastic leukemia via miR-9/PD-L1 axis.

Authors:  Junjie Yin; Qingsong Yin; Bo Liang; Ruihua Mi; Hao Ai; Lin Chen; Xudong Wei
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2019-12-14       Impact factor: 3.000

3.  LINC00665/miR-9-5p/ATF1 is a novel axis involved in the progression of colorectal cancer.

Authors:  Xuhong Zhao; Wenhao Weng; Yin Long; Weijie Pan; Zhi Li; Fenyong Sun
Journal:  Hum Cell       Date:  2020-08-10       Impact factor: 4.174

Review 4.  The Complex Landscape of PTEN mRNA Regulation.

Authors:  Erin Sellars; Martino Gabra; Leonardo Salmena
Journal:  Cold Spring Harb Perspect Med       Date:  2020-06-01       Impact factor: 5.159

5.  Long non‑coding RNA NEAT1 promotes ovarian cancer cell invasion and migration by interacting with miR‑1321 and regulating tight junction protein 3 expression.

Authors:  Min Luo; Lei Zhang; Hongying Yang; Kaili Luo; Chen Qing
Journal:  Mol Med Rep       Date:  2020-08-11       Impact factor: 2.952

6.  LncRNA NEAT1 enhances the resistance of anaplastic thyroid carcinoma cells to cisplatin by sponging miR‑9‑5p and regulating SPAG9 expression.

Authors:  Pei Yan; Zijie Su; Zhenhua Zhang; Teng Gao
Journal:  Int J Oncol       Date:  2019-09-04       Impact factor: 5.650

7.  NEAT1 promotes retinoblastoma progression via modulating miR-124.

Authors:  Lufei Wang; Defeng Yang; Rui Tian; Hui Zhang
Journal:  J Cell Biochem       Date:  2019-04-30       Impact factor: 4.429

8.  Long Non-coding RNA NEAT1 as an Emerging Biomarker in Breast and Gynecologic Cancers: a Systematic Overview.

Authors:  Sanu Thankachan; Boddapati Kalyani Bhardwaj; Thejaswini Venkatesh; Padmanaban S Suresh
Journal:  Reprod Sci       Date:  2021-02-10       Impact factor: 3.060

9.  POU2F1 Promotes Cell Viability and Tumor Growth in Gastric Cancer through Transcriptional Activation of lncRNA TTC3-AS1.

Authors:  Jixu Wang; Ke Xiao; Futao Hou; Lusheng Tang; Dan Luo; Gu Liu; Zhiqiang Wang
Journal:  J Oncol       Date:  2021-06-28       Impact factor: 4.375

10.  Long Non-Coding RNA 691 Regulated PTEN/PI3K/AKT Signaling Pathway in Osteosarcoma Through miRNA-9-5p.

Authors:  Pengju Yao; Yangming Ni; Changlu Liu
Journal:  Onco Targets Ther       Date:  2020-05-22       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.